EXEL 8-K 2026-01-12

EXELIXIS, INC. (EXEL) 8-K dated 2026-01-12 — accession 0000939767-26-000003. This URL is the filing, not the EXEL hub.

EXELIXIS, INC. (EXEL) is a biotechnology company listed on US.

EXELIXIS, INC. filed a 8-K on 2026-01-12. Accession 0000939767-26-000003.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported EXEL revenue for 2026-07-03 was $628.7M. Net income was $212.1M. Revenue was up 2.9% from 2026-04-03 to 2026-07-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.

Not investment advice. The EXEL SEC hub lists recent forms. The stock page is the research view.